Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xingpi Yanger granule
- Development stage
- Unknown
- Lead developer
- Guizhou Jianxing Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xingpi Yanger granule is a Traditional Chinese Medicine (TCM) product primarily used in pediatric care for the treatment of infantile diarrhea, anorexia, and malnutrition associated with spleen deficiency. Developed and manufactured by Guizhou Jianxing Pharmaceutical, the formulation is composed of four herbal extracts: *Elsholtzia splendens* (Mao Xiang Hua), *Ilex chinensis* (Shan Zhi Cha), *Centipeda minima* (Shi Hu Sui), and *Chrysanthemum indicum* (Ye Ju Hua). The drug is designed to "awaken the spleen" and "nourish the child," addressing symptoms such as loose stools, poor appetite, restlessness, and night sweating. It is widely utilized in China as both a monotherapy and an adjuvant treatment alongside Western medicines like probiotics or antibiotics for gastrointestinal and respiratory conditions.
- Brand names
- Xingpi Yanger
- Other names
- Xingpi Yanger KeliXingpi Yanger granules醒脾养儿颗粒
Beyond the preview
Go deeper on Xingpi Yanger granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xingpi Yanger granule.